Metastatic Mechanism Research and Potential Target Screening of Biliary Tract Cancer Based on Multi-omics

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300075173

Enrollment

Unknown

Registered

2023-08-28

Start date

2023-09-01

Completion date

Unknown

Last updated

2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary tract cancer

Interventions

Biliary tract cancer with liver metastasis group:NA

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years old; 2. Primary biliary tract cancer with liver metastasis; 3. Preoperative imaging indicated porta hepatis lymph node metastasis; 4. The patients did not receive chemoradiation, immunization or targeted therapy before surgery; 5. The patients voluntarily participated in the study and signed the informed consent

Exclusion criteria

Exclusion criteria: 1. Insufficient data quality; 2. Combined with other site tumors; 3. Family history of cancer; 4. Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, etc.

Design outcomes

Primary

Measure	Time frame
Genomic characteristics;Epigenetic characteristics;	—

Secondary

Measure	Time frame
Single-cell proteomic characteristics;The immune microenvironmental characteristics;Spatiotemporal transcriptional characteristics;	—

Countries

China

Contacts

Public ContactMingyu Chen

Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine

mychen@zju.edu.cn+86 178 5777 2223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026